Haizheng 1.1 new drug dtrmhs-07 is qualified for CDE special approval
-
Last Update: 2015-01-28
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Although dtrmhs-07, a new drug of category 1.1 declared by Zhejiang Haizheng at the end of last year, failed to catch up with the last bus of 2014, it made a good start in the new year CDE undertook the Declaration on January 19, 2015, and the acceptance number entered the evaluation center Dtrmhs-07 is a nervous system drug, but its target and indications have not been known At present, dtrmhs-07 is queuing in the ind sequence for review, and the latest queue number is shown in Table 1 At the same time, on January 27, the drug obtained the qualification of special approval variety review Dtrmhs-07 is the first class 1.1 new drug declared by Zhejiang Haizheng this year After the drug entered the review center on January 19, the stock of Haizheng Pharmaceutical (sh600267) rose by 3.52% on January 20 At present, the stock is still rising
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
